Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insights™ Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. ...

Multiple Sclerosis Drugs Market to Hit USD 40.66 Bn by 2027; Promising Research into Developing Efficient MS Therapies to Prove Beneficial for the Market: Fortune Business Insights™ Pune, July 30, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High...

Multiple Sclerosis Market: 2020 Drivers, Restraints, Drug Class, Diagnosis, End-Users, Distribution Channel, Industry SWOT Analysis and Company Profiles Opexa Therapeutics, Inc, Actelion Pharmaceuticals Ltd WILMINGTON, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size, Status and Forecast 2020-2027 its latest research report released by Data Bridge Market Research. The market report...

Multiple Sclerosis Drugs Market to Reach US$ 39,289.5 Mn by 2026,at a CAGR of 6.7%, Leading Companies Focus on Strategic Collaborations to Expand their Footprint, says Fortune Business Insights Pune, July 19, 2019 (GLOBE NEWSWIRE) -- The global Multiple Sclerosis Drugs Market is expected to gain from the development of economical therapy to treat multiple sclerosis (MS), finds Fortune...